The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The Rising Prevalence of Diabetes

• Diabetes causes high blood glucose levels, damaging the retina.
• Global diabetes prevalence was 10.5% in 2021, with projections to rise.
• The diabetic population is expected to increase from 643 million in 2030 to 783 million by 2045.

Major Players in the Diabetic Retinopathy Market

• Pfizer Inc., F-Hoffmann-La Roche Ltd., Novartis AG, and others are key players.
• Companies focus on developing treatments and diagnostic tools for diabetic retinopathy.

Technological Evolution In Diabetic Retinopathy Detection

Adoption of Advanced Technologies

• Companies like Baxter International Inc. introduce new technologies for diabetic retinopathy detection.
• The Welch Allyn RetinaVue 100 Imager PRO allows for retinal exams in primary care settings.

Read More On The Diabetic Retinopathy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report

Meteda’s Acquisition Of Retmarker SA Unveiled

Expansion through Acquisition

• Meteda, a US-based healthcare technology company, acquired Retmarker SA.
• The acquisition strengthens Meteda’s presence in the EMEA region and enhances AI capabilities in diabetic retinopathy management.

Segmentation of the Diabetic Retinopathy Market

Types of Diabetic Retinopathy

• Proliferative Diabetic Retinopathy
• Non-Proliferative Diabetic Retinopathy

Treatment Options

• Anti-VEGF Drugs
• Intraocular Steroid Injection
• Laser Photocoagulation
• Vitreoretinal Surgery

End-User Segments

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

Regional Outlook

North America Dominates

• North America led the diabetic retinopathy market in 2023.
• Key factors include advanced healthcare infrastructure and high diabetes prevalence.

Rapid Growth in Asia-Pacific

• Asia-Pacific is poised to witness the fastest growth in the forecast period.
• Increasing healthcare expenditure and growing awareness contribute to this trend.

Conclusion

The diabetic retinopathy market demonstrates significant growth potential driven by the rising prevalence of diabetes worldwide. Technological advancements and strategic acquisitions enhance diagnostic capabilities and expand market reach. With a focus on precision medicine and early detection, the market is poised for continued expansion, especially in regions like Asia-Pacific. As major players innovate and collaborate, the outlook for diabetic retinopathy management looks promising, offering hope for improved patient outcomes and quality of life.

Request for A Sample Of The Global Diabetic Retinopathy Market Report:

https://www.thebusinessresearchcompany.com/sample_request?id=12187&type=smp